Wakabayashi Mami, Ezoe Satoshi, Yoneda Makiko, Katsuma Yasushi, Iso Hiroyasu
Institute for Global Health Policy Research, Bureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan.
Global Health Policy Division, International Cooperation Bureau, Ministry of Foreign Affairs, Tokyo, Japan.
GHM Open. 2022 Aug 31;2(1):44-50. doi: 10.35772/ghmo.2021.01029.
Ensuring equitable access to COVID-19 vaccines for all people has been challenging, hence, establishing relevant vaccination policies is required. This study delineates how vaccination policies have affected equitable access to COVID-19 vaccines. A situation survey was conducted in 201 countries and territories through 156 Japanese diplomatic missions abroad to capture the global state of COVID-19 vaccination policies. Questionnaire responses were received from 159 states (79%) as of March 31, 2021, and data from Japan were incorporated into the analysis. All questionnaire items were open-ended, covering the vaccines in use and five vaccination policies such as vaccine eligibility. Results reveal that first, 81 states (51% out of 160) had not started vaccinations as of February 24, 2021, but by March 31, this number had decreased dramatically to 37 (23%); in particular, the number of states in Africa without vaccination decreased from 40 to 16. Second, 43 (27%) states did not recommend the vaccine for pregnant women. Third, the vaccine was free of charge to the public in 116 states (73%), and 43 states (27%) offered no-fault compensation. Finally, vaccination was voluntary in 124 states (78%). In conclusion, the number of countries that had started vaccination increased by March 2021, especially in Africa, although many African countries seemed to lack access to the mRNA vaccine. To fix the uneven distribution, dose donations were accelerated since middle of July. Reviewing worldwide vaccine policies is useful not only for this pandemic but also to strengthen vaccination systems for preparedness for the next pandemic.
确保所有人都能公平获得新冠疫苗具有挑战性,因此,需要制定相关的疫苗接种政策。本研究阐述了疫苗接种政策如何影响新冠疫苗的公平可及性。通过日本驻外156个外交使团在201个国家和地区进行了情况调查,以掌握全球新冠疫苗接种政策的状况。截至2021年3月31日,收到了159个国家(79%)的问卷调查回复,并将日本的数据纳入分析。所有问卷项目均为开放式,涵盖了正在使用的疫苗以及疫苗资格等五项疫苗接种政策。结果显示,首先,截至2021年2月24日,81个国家(160个国家中的51%)尚未开始接种疫苗,但到3月31日,这一数字大幅降至37个(23%);特别是非洲未接种疫苗的国家数量从40个减少到16个。其次,43个(27%)国家不建议孕妇接种疫苗。第三,116个国家(73%)的疫苗对公众免费,43个国家(27%)提供无过错补偿。最后,124个国家(78%)的疫苗接种是自愿的。总之,到2021年3月,开始接种疫苗的国家数量有所增加,尤其是在非洲,尽管许多非洲国家似乎无法获得mRNA疫苗。为了解决分配不均的问题,自7月中旬以来加快了疫苗剂量捐赠。审查全球疫苗政策不仅对本次疫情有用,而且有助于加强疫苗接种系统,为下一次疫情做好准备。